The present disclosure relates generally to blood collection devices and, more particularly, to flexible capillary tubes with integrated luer caps.
Patients with intravenous (IV) catheters may require blood testing for determining the presence of infection, such as sepsis, or other for collecting other information about the patient. Sepsis commonly causes widespread inflammation (swelling) in the body, inflammation, and blood clotting during sepsis commonly causes reduced blood flow to limbs and vital organs, which can lead to organ failure and even death. So it is important to detect it as soon as possible. Sepsis occurs when germs get into a person's body. Bacterial infections cause most cases of sepsis. Patients requiring IV catheters commonly have suppressed immune systems, so it is important to limit contamination as much as possible. Typically, when a patient needs blood drawn, a needle and syringe are used to draw the blood directly from the patient or an external syringe is used to draw blood from the catheter port. One drawback to drawing blood directly from a catheter port using a syringe is a high chance of contamination in the catheter port.
Accordingly, those skilled in the art continue research and development efforts in the field of drawing blood through existing catheter ports.
Disclosed is a medical device.
In one example, the medical device includes a luer cap, a needle housed in the luer cap, a luer tube in fluid communication with the needle, an actuator coupled at least one of the needle and the tube, and a spring operatively associated with the actuator.
The needle may be removably coupleable with the luer tube. The luer cap may include an inside surface and wherein the inside surface may be threaded.
The medical device may further include a vacuum collection tube removably coupled to the luer cap. The vacuum collection tube may define a vacuum chamber. The vacuum collection tube may include a distal end, a proximal end opposed from the distal end, a scaling cap positioned over the proximal end, and a septum coupled to the sealing cap.
The sealing cap may include an outside surface, the outside surface comprising a plurality of ribs. The needle may be movable between at least a first position and a second position. In the first position, the needle may be located below the septum and in the second position, the needle may be pierced through the septum and at least partially received within the vacuum chamber. Upon piercing through the septum, a vacuum may be drawn from the luer tube toward the vacuum chamber.
Also disclosed is a system for drawing blood from a patient.
In one example, the system includes a catheter hub, a catheter tube in fluid communication with the catheter hub, and a medical device removably coupleable to a portion of the catheter hub. The medical device includes a luer cap, a needle housed in the luer cap, a luer tube in fluid communication with the needle, an actuator coupled at least one of the needle and the tube, a spring operatively associated with the actuator, a vacuum collection tube removably coupled to the luer cap, the vacuum collection tube defining a vacuum chamber.
The luer tube may be removably coupleable with the catheter hub such that they are in fluid communication. The luer tube may be removably coupleable with the catheter tube such that they are in fluid communication. The luer tube may nest in the catheter tube. The medical device may be threadedly engageable with a portion of the catheter hub. The vacuum collection tube may include a distal end, a proximal end opposed from the distal end, a sealing cap positioned over the proximal end, and a septum coupled to the sealing cap. The sealing cap may be removably coupleable with the luer cap.
The needle may be movable between at least a first position, wherein the needle may be located below the septum, and a second position, wherein the needle may be pierced through the septum and at least partially received within the vacuum chamber. The actuator may facilitate movement of the needle from the first position and the second position, and wherein the spring facilitates movement of the needle and actuator from the second position to the first position. Upon piercing through the septum, a vacuum may be drawn from catheter tube toward the vacuum chamber to draw a blood sample from the patient.
Also disclosed is a method for testing a blood sample drawn through a catheter tube into a medical device including a luer cap, a needle housed in the luer cap, a luer tube in fluid communication with the needle, an actuator coupled at least one of the needle and the tube, a spring operatively associated with the actuator, and a vacuum collection tube coupled to the luer cap.
In one example, the method includes coupling the medical device with the catheter tube such that they are in fluid communication, actuating the actuator from a first position to a second position, drawing the blood sample into the vacuum collection tube, uncoupling the medical device from the catheter tube, and testing the blood sample.
The coupling may include coupling the medical device with a catheter hub in fluid communication with the catheter tube. The coupling and actuating occur concurrently. The method may further include transmitting data collected during the testing to a medical management system.
The above-mentioned and other features and advantages of this disclosure, and the manner of attaining them, will become more apparent and the disclosure itself will be better understood by reference to the following descriptions of embodiments of the disclosure taken in conjunction with the accompanying drawings, wherein:
Corresponding reference characters indicate corresponding parts throughout the several views. The exemplifications set out herein illustrate exemplary embodiments of the disclosure, and such exemplifications are not to be construed as limiting the scope of the disclosure in any manner.
Spatial or directional terms, such as “left”, “right”, “inner”, “outer”, “above”, “below”, and the like, are not to be considered as limiting as the invention can assume various alternative orientations.
All numbers used in the specification and claims are to be understood as being modified in all instances by the term “about”. By “about” is meant a range of plus or minus ten percent of the stated value. As used in the specification and the claims, the singular form of “a”, “an”, and “the” include plural referents unless the context clearly dictates otherwise. The terms “first”, “second”, and the like are not intended to refer to any particular order or chronology, but instead refer to different conditions, properties, or elements. By “at least” is meant “greater than or equal to”.
As used herein, the terms “communication” and “communicate” refer to the receipt or transfer of one or more signals, messages, commands, or other type of data. For one unit (e.g., any device, system, or component thereof) to be in communication with another unit means that the one unit is able to directly or indirectly receive data from and/or transmit data to the other unit. This may refer to a direct or indirect connection that is wired and/or wireless in nature. Additionally, two units may be in communication with each other even though the data transmitted may be modified, processed, relayed, and/or routed between the first and second unit. For example, a first unit may be in communication with a second unit even though the first unit passively receives data and does not actively transmit data to the second unit. As another example, a first unit may be in communication with a second unit if an intermediary unit processes data from one unit and transmits processed data to the second unit. It will be appreciated that numerous other arrangements are possible.
It will be apparent that systems and/or methods, described herein, can be implemented in different forms of hardware, software, or a combination of hardware and software. The actual specialized control hardware or software code used to implement these systems and/or methods is not limiting of the implementations. Thus, the operation and behavior of the systems and/or methods are described herein without reference to specific software code, it being understood that software and hardware can be designed to implement the systems and/or methods based on the description herein.
Although the invention has been described in detail for the purpose of illustration based on what is currently considered to be the most practical and preferred embodiments, it is to be understood that such detail is solely for that purpose and that the invention is not limited to the disclosed embodiments, but, on the contrary, is intended to cover modifications and equivalent arrangements that are within the spirit and scope of the appended claims. For example, it is to be understood that the present invention contemplates that, to the extent possible, one or more features of any embodiment can be combined with one or more features of any other embodiment.
The disclosed is a solution for streamlining detection of blood conditions, such as sepsis or other infection. The following are the signs and symptoms of sepsis: shortness of breath, high heart rate, fever, or shivering, or feeling very cold, severe muscle pain etc. The three stages of sepsis are: sepsis, severe sepsis, and septic shock. When a patient's immune system goes into overdrive in response to an infection, sepsis may develop as a result.
Sepsis is often diagnosed by simple measurements such temperature, heart rate and breathing rate, and blood testing. Other tests can help determine the type of infection, where it's located and which body functions have been affected. The following different biomarkers used in sepsis identification are CRP (C-reactive protein), PCT (Procalcitonin), Interleukin (IL)-6, Presepsin are the biomarkers that have been studied most frequently. Based on the research it has been identified that Interleukin (IL)-6 biomarker will be the effective and accurate for detection of the sepsis infection. These Interleukin (IL)-6 acts as both a pro-inflammatory and anti-inflammatory cytokine. The blood samples will be used as a matrix for identifying biomarkers is widely used in the detection of Sepsis.
The disclosure allows for extracting pure/fresh blood samples from deep in the Intravenous line through the catheter port by modifying existing CCMD products, such as the BD PureHub Disinfection Unit (DU) Cap. The disclosure integrates flexible capillary tubes and vacuum blood collection tubes with a luer cap (Modified BD PureHub Cap) that can be used to extract blood from patients, which will then be used to analyze the detection of sepsis.
At the proximal end of the Luer cap is a small hole and a circular rubber septum is positioned at the circumference of the hole. At the top of luer cap a vacuum blood collection tube may be fixed, which can be used to collect the fresh blood samples. The rubber septum helps to maintain a vacuum inside the blood collection tube by restricting the entry of outer atmosphere air. The one end of the flexible capillary tube is attached to the hallow bevel needle, the other end will be inserted into the vein for blood draw. At the proximal end of thread a free space houses an actuator and spring. The actuator may have lug design, which is seated on the circumference of the last thread profile and inside the actuator the spring were assembled, which will provide a cushioning effect to actuator when it get compressed against the catheter port. The flexible capillary tube is attached in fluid path communication with the needle, which is assembled with the actuator through, for example, interference fit.
In the proposed clinical state after catheterization, the luer cap Integrated with flexible capillary tube and vacuum blood collection tube are removably coupleable to a peripheral IV catheter through a threaded connection to collect a rich blood samples from vein. The flexible capillary tube may be advanced through the PIVC line, and may extend beyond the catheter tip, and enter the vessel to collect a fresh/pure blood sample. This flexible capillary tube is designed to extend beyond the suboptimal draw conditions around the IV to reach vessel locations where blood flow is optimal for aspiration. Once the luer cap is fully threaded with catheter port, the actuator will compress against catheter port, which in turn make the needle to pierce the septum and reaches the vacuumed blood collection tube. Due to the capillary and/or vacuum effect, the blood from the vein (high pressure area) will be traveling to the vacuum blood collection tube (low pressure area) through the flexible capillary tube. Once a desired mL of blood is collected in the blood collection tube, the threaded connection can be removed from the catheter port, which in turn makes the actuator enables the needle to travel back to its original position. When the needle returns to its original position, the septum becomes closed. Once the blood has been collected in the vacuum blood collection tube, the snaps will be separated from the luer cap, and the vacuum blood collection tube will be taken out separately. Blood into multiple vacuum tubes can be collected by attaching new tube at the back of the luer cap. The sealing cap keeps the blood sample in the vacuum tube free of external contaminant. Alternatively, the primary sealing cap can be removed from the vacuum tube, and a secondary sealing cap can replace it to close the blood collection tube and keep in the blood centrifuge machine for further blood test/blood culture evaluation.
The disclosure utilizes a vacuum blood collection tube and flexible capillary tube integrated with the currently commercially available Catheter Care disinfectant unit (DU) cap profile, which can be inserted into a Y port adapter of an IV catheter. Once the DU cap is inserted the pathway to the vacuum blood collection tube opens and the blood can flow from vein to the vacuum blood collection tube through the flexible capillary tube (blood starts flowing from high pressure area to low pressure area). This device can be assembled with any open IV catheter and can be assembled with any closed catheters through the side or Y ports.
Referring to
The medical device 100 further includes a needle 140 housed in the luer cap 130. The needle 140 is movable between at least a first position and a second position, as described below.
Still referring to
Still referring to
Still referring to
Still referring to
Referring to
Referring to
Still referring to
The medical device 100 includes a luer cap 130, a needle 140 housed in the luer cap 130, a luer tube 170 in fluid communication with the needle 140, an actuator 160 coupled at least one of the needle 140 and the luer tube 170, a spring 150 operatively associated with the actuator 160, and a vacuum collection tube 110 removably coupled to the luer cap 130, the vacuum collection tube 110 defining a vacuum chamber 116.
In one example, the luer tube 170 is removably coupleable with the catheter hub 210 such that they are in fluid communication, see
The vacuum collection tube 110 includes a distal end 112, a proximal end 114 opposed from the distal end 112, a sealing cap 180 positioned over the proximal end 114, and a septum 120 coupled to the sealing cap 180. In one example, the sealing cap 180 of the vacuum collection tube 110 is removably coupleable with the luer cap 130.
The needle 140 of the medical device 100 is movable between at least a first position and a second position. The needle 140 is located below the septum 120 in the first position and the needle 140 is pierced through the septum 120 and at least partially received within the vacuum chamber 112 in the second position.
The actuator 160 of the system 200 facilitates movement of the needle 140 from the first position and the second position, and wherein the spring 140 facilitates movement of the needle 140 and actuator 160 from the second position to the first position. Upon piercing through the septum 120, a vacuum is drawn from catheter tube 220 toward the vacuum chamber 112 to draw a blood sample from the patient 230. Due to a capillary effect, the blood from the vein (high pressure area) will travel to the vacuum collection tube 110 (low pressure area) through the luer tube 170 and needle 140 in fluid communication with the luer tube 170.
After an adequate amount of blood has been drawn from the patient 230 to the vacuum collection tube 110, the vacuum collection tube 110 is configured to be uncoupled from the medical device 100 and can then be taken to another location for testing the blood sample, such as with a blood testing apparatus 250. In one example, the blood testing apparatus 250 is an electrochemical immunoassay.
In one example, after uncoupling from the medical device 100, the scaling cap 180 may be removed from the vacuum collection tube 110 and a secondary sealing cap 186 may replace the sealing cap 180 for a closed fit for transporting to other storage areas, such as a centrifuge machine, for further blood testing and blood culturing. The secondary sealing cap 186 may be a single, monolithic piece that does not have a septum 120 or other opening.
Referring to
Still referring to
Still referring to
Still referring to
Still referring to
Still referring to
The method 300 may further include transmitting 360 data collected during the testing 350 to a medical management system 260. The blood testing device 250 may be in communication with the medical management system 260, such as wireless communication, to transmit the data for storage in a cloud or on a server, or for transmitting the data to a computer/phone for viewing and further analyzing the data collected from the testing 350.
Although non-limiting embodiments have been described in detail for the purpose of illustration and description, it is to be understood that such detail is solely for that purpose and that embodiments are not limited to the disclosed embodiments, but, on the contrary, are intended to cover modifications and equivalent arrangements that are within the spirit and scope of the appended claims. For example, it is to be understood that the present disclosure contemplates that, to the extent possible, one or more features of any embodiment or aspect can be combined with one or more features of any other embodiment or aspect. In fact, many of these features can be combined in ways not specifically recited in the claims and/or disclosed in the specification. Although each dependent claim listed below may directly depend on only one claim, the disclosure of possible implementations includes each dependent claim in combination with every other claim in the claim set.